Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-041774

President and CEO sold 2,115 shares at $5.18 ($10,948)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-07-08 Sale : show line 1 in the form −2,115 $5.18 $10,948 628,791 D
Open-market sales · 2,115 sh · avg $5.18 · $10,948
Loading xslF345X03/doc4.xml…